Aignostics brings PathoSearch to Techcyte Fusion AP

Techcyte said Aignostics has joined its Fusion Partner Program and integrated PathoSearch into Fusion AP, giving pathologists image-based search for similar cases directly inside the slide viewer. The early-access workflow will be shown this week at the European Congress of Pathology in Stockholm.

Why it matters: - The integration gives pathologists a faster way to find morphologically similar cases when a finding is rare, unfamiliar or difficult to classify. - The workflow keeps users inside the Fusion AP slide viewer, which can reduce friction during case review. - Researchers can use the same tool to search for similar morphology across a large reference set.

What happened: - Techcyte said Aignostics has joined the Techcyte Fusion® Partner Program. - The companies integrated Aignostics’ PathoSearch application into Techcyte Fusion AP. - The announcement came Sept. 12, 2026, from Berlin and Orem, Utah. - Techcyte said the integrated workflow will be demonstrated at the 38th European Congress of Pathology in Stockholm, Sept. 12–16, at booth 539 in Hall B.

The details: - PathoSearch lets pathologists search for morphologically similar cases from within the slide viewer using the image itself rather than a written description. - The tool uses embeddings from Atlas 2, Aignostics’ pathology foundation model co-developed with Mayo Clinic. - PathoSearch compares a selected region of an H&E whole slide image with a curated, multi-center reference database of diagnosed cases. - The reference set is annotated and validated by pathologists. - At launch, PathoSearch covers more than 310,000 whole slide images from over 35,000 cases. - The database spans more than 300 diagnostic entities across 27 organs. - From Fusion AP, users select a region of interest in an image, and Fusion AP passes the image to PathoSearch without export or upload. - Results open in Aignostics’ platform and show similar cases and related information. - PathoSearch currently supports thoracic, digestive, soft tissue and bone, female genital, and urinary and male genital cancers. - Aignostics plans additional malignancies over time. - PathoSearch is in early access, and Fusion AP users can request access through their Techcyte contact. - Techcyte said PathoSearch and Fusion AP are for Research Use Only in the United States and are not for diagnostic use. - More information about the Techcyte Fusion Partner Program is available here. - Aignostics’ website is www.aignostics.com, and its LinkedIn page is LinkedIn.

Between the lines: - The integration ties a diagnostic workflow tool to a case-search engine built on real, diagnosed cases. - Aignostics said PathoSearch is aligned to the WHO Classification of Tumours. - Techcyte and Aignostics framed the collaboration as a way to put reference material in front of pathologists at the moment they need it. - This is the first step in a broader collaboration, with more integrations and capabilities planned in Fusion AP in the coming months.

What's next: - Techcyte and Aignostics will continue showing the integrated workflow at ECP in Stockholm. - The companies expect to add more integrations and capabilities within Fusion AP over the next few months. - Fusion AP users interested in PathoSearch access will need to go through their Techcyte contact.

The bottom line: - Techcyte is turning Fusion AP into a more interactive pathology workflow by adding image-based case search from Aignostics directly in the viewer.